| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/04/2001 | WO2001072323A2 Use of insulin for the treatment of cartilagenous disorders |
| 10/04/2001 | WO2001072319A1 Tea catechin formulations and processes for making same |
| 10/04/2001 | WO2001072318A1 Tea catechins in sustained release formulations as cancer specific proliferation inhibitors |
| 10/04/2001 | WO2001072315A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 10/04/2001 | WO2001072310A1 Pharmaceutical gel composition |
| 10/04/2001 | WO2001072301A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 10/04/2001 | WO2001072300A1 Uses of metal salts to stabilize taxane-based compositions |
| 10/04/2001 | WO2001072299A1 Taxane-based compositions and methods of use |
| 10/04/2001 | WO2001072286A1 Sustained release vitamin composition |
| 10/04/2001 | WO2001072284A1 Granulated particles with masked taste |
| 10/04/2001 | WO2001072283A1 Cationic liposomes |
| 10/04/2001 | WO2001072282A1 Self-emulsifying matrix type transdermal preparation |
| 10/04/2001 | WO2001072281A2 Microspheres for active embolization |
| 10/04/2001 | WO2001072280A2 Microspheres for gene therapy |
| 10/04/2001 | WO2001072279A2 Medical emulsion for lubrication and delivery of drugs |
| 10/04/2001 | WO2001072278A2 Method for administering insulin to the buccal region |
| 10/04/2001 | WO2001072277A2 Immunotherapeutic methods and compositions |
| 10/04/2001 | WO2001072267A1 Cosmetic composition comprising at least a non-polymeric crystalline salt |
| 10/04/2001 | WO2001072264A2 Pro-liposomal encapsulated preparations (iv) |
| 10/04/2001 | WO2001072138A1 Chewing gum containing sulfurated amino acid compounds |
| 10/04/2001 | WO2001072136A1 Sterol ester compositions |
| 10/04/2001 | WO2001044198A8 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules |
| 10/04/2001 | WO2001043704A8 A skin care composition that mediates cell to cell communication |
| 10/04/2001 | WO2001024780A3 Soft gel capsule resistant to gastric juices |
| 10/04/2001 | WO2001019335A3 Composition to be administered through mucous membrane |
| 10/04/2001 | WO2001019321A3 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides |
| 10/04/2001 | WO2001013956A3 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 10/04/2001 | WO2001012214A3 MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a) |
| 10/04/2001 | WO2001005429A3 Powder particles with smooth surface for use in inhalation therapy |
| 10/04/2001 | WO2001004195A8 Film coatings and film coating compositions based on polyvinyl alcohol |
| 10/04/2001 | US20010027311 Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| 10/04/2001 | US20010027215 Pulse administering of a C1-C4 substituted and/or phenyl substituted carboxylic acid and salts and a carrier or diluent to stimulate cells in treating blood disorders, e.g. sickle cell anemia, thalassemia, blood loss etc. |
| 10/04/2001 | US20010027212 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 10/04/2001 | US20010027192 A gastrointestinal mucosa-adherent solid comprising an anti-Helicobacter pylori antibiotic and a proton pump inhibitor (antiulcer); synergistic; potentiation; side effect reduction |
| 10/04/2001 | US20010027191 Soluble forms of amoxicillin and treatment of animals |
| 10/04/2001 | US20010027188 Ophthalmic composition for keratoconjunctivitis sicca (dry eye) |
| 10/04/2001 | US20010027180 GLP-2 formulations |
| 10/04/2001 | US20010027178 And a hydrophilic organic solvent and a surfactant; low cost, the glyceride is a good solvent for cyclosporin |
| 10/04/2001 | US20010027177 Pharmaceutical composition containing a small or medium size peptide |
| 10/04/2001 | US20010027172 Made by decarboxylation of the corresponding fluoroalkyl ether carboxylic acids; use in fluorinated polyether deposition, soldering, and cleaning and drying; low boiling, shorter atomospheric life, less harmful to ozone layer |
| 10/04/2001 | US20010026937 Culturing population of peripheral blood or bone marrow mononuclear cells in interleukin-4, granulocyte macrophage colony stimulating factor, and culture medium comprising insulin, transferrin, linoleic acid, oleic acid, palmitic acid |
| 10/04/2001 | US20010026915 Spectral changes in biopolymer |
| 10/04/2001 | US20010026814 Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 10/04/2001 | US20010026812 Method for determining the three-dimensional structure of a protein |
| 10/04/2001 | US20010026810 Polyurethane prepolymer with polyoxyethylene, polyoxypropylene or propylene glycol; absorbtive, contours to wound site; maintains moisture for healing; may contain fungicidal, bactericidal and deodorizing additives |
| 10/04/2001 | US20010026809 Immediate release tablet cores of insoluble drugs having sustained-release coating |
| 10/04/2001 | US20010026808 Non-steroidal anti inflammatory drug and misoprostol in the form of non-breakable coated pellets; side effect reduction |
| 10/04/2001 | US20010026807 Starch coating capsule of ph redox sensitive material broken down by enzymes or bacteria in colon; absorbtion |
| 10/04/2001 | US20010026806 Antibacterial phosphoinositides technical field |
| 10/04/2001 | US20010026805 Optically clear products having enhanced stability in syrup and bioavailability; surfactant matches fatty acid profile of oil soluble ingredient |
| 10/04/2001 | US20010026804 Compressed microparticles for dry injection |
| 10/04/2001 | US20010026802 Protective coatings, adhesive resins for laminated wood products, pesticides dispensers; |
| 10/04/2001 | US20010026800 Delivering an immunogen to a preselected region of the gastrointestinal tract |
| 10/04/2001 | US20010026795 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 10/04/2001 | US20010026793 Drug delivery matrix, surgery device |
| 10/04/2001 | US20010026788 Method of producing a nicotine medicament and a medicament made by the method |
| 10/04/2001 | EP1138661A1 Pulverised mannitol and process for its preparation |
| 10/04/2001 | EP1138337A2 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| 10/04/2001 | EP1138333A1 Medicinal compositions for oral use |
| 10/04/2001 | EP1138322A2 Capsules comprising polymers of vinylesters and polyethers, their use and their preparation |
| 10/04/2001 | EP1138321A2 Solid oral dosage forms with sustained drug release and high mechanical stability |
| 10/04/2001 | EP1138320A2 Floating forms containing drug, polyvinyl acetate and polyvinyl pyrrolidone, their use and preparation |
| 10/04/2001 | EP1138319A2 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| 10/04/2001 | EP1138315A1 Roll-on applicator containing a hair-treating composition |
| 10/04/2001 | EP1138314A2 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 10/04/2001 | EP1138313A1 Proliposomes |
| 10/04/2001 | EP1138310A1 Proliposomes |
| 10/04/2001 | EP1137813A1 Method of drying a lactulose solution |
| 10/04/2001 | EP1137805A1 Methods of facilitating vascular growth |
| 10/04/2001 | EP1137762A1 Treatment of pompe's disease |
| 10/04/2001 | EP1137671A1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
| 10/04/2001 | EP1137497A1 Apparatus for separating particles of cohesive material according to size and process |
| 10/04/2001 | EP1137440A1 A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes |
| 10/04/2001 | EP1137433A2 Pharmaceutical compositions containing protein-disulfide isomerases |
| 10/04/2001 | EP1137431A1 Pharmaceutical compositions containing insulin |
| 10/04/2001 | EP1137430A2 Therapeutic agent for the suppression of snoring noises |
| 10/04/2001 | EP1137422A2 Use of human prostate cell lines in cancer treatment |
| 10/04/2001 | EP1137411A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 10/04/2001 | EP1137409A2 Compositions and methods for amelioration of human female sexual dysfunction |
| 10/04/2001 | EP1137407A1 The process for manufacturing formulation of topical beta blockers with improved efficacy |
| 10/04/2001 | EP1137406A2 Transdermal patch for delivering volatile liquid drugs |
| 10/04/2001 | EP1137405A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof |
| 10/04/2001 | EP1137404A2 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations |
| 10/04/2001 | EP1137403A1 Sustained release tablet containing hydrocolloid and cellulose ether |
| 10/04/2001 | EP1137402A1 Phospholipid compositions |
| 10/04/2001 | EP1137401A1 Administration of neurotrophic agents to the central nervous system |
| 10/04/2001 | EP1137400A1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period toff, verfahren zu seiner herstellung und anlage zur durchfuhrung des verfahrens |
| 10/04/2001 | EP1137399A2 Improvements in or relating to powders |
| 10/04/2001 | EP1137398A1 Pharmaceutical preparation for inhalation of an opioid |
| 10/04/2001 | EP1137373A1 Biocompatible crosslinked polymers |
| 10/04/2001 | EP1137344A1 Preparation of cholesterol reducing edible products by mixing plant sterols/stanols in a melt of a food emulsifier |
| 10/04/2001 | EP0950408B1 Oily patches for external use containing diclofenac sodium |
| 10/04/2001 | EP0869772B1 Bioadhesive solid dosage form |
| 10/04/2001 | EP0833616B1 Process for the continuous agglomeration of granules |
| 10/04/2001 | EP0802796B1 Chicken anaemia agent broiler vaccine |
| 10/04/2001 | EP0748342B1 Block and graft copolymers and methods relating thereto |
| 10/04/2001 | EP0682524B1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 10/04/2001 | EP0674646B1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| 10/04/2001 | DE10108251A1 Verabreichung eines Medikaments mittels Mikro-Verkapselung Administration of a drug by means of micro-encapsulation |